AorTech plans expansion through a combination of new technology and manufacturing and distribution deals
This article was originally published in Clinica
Executive Summary
Scottish cardiovascular company AorTech has high hopes for the new heart valve it is developing. In the meantime it has signed a European manufacturing deal with Novoste in the US. Managing director Eddie McDaid spoke to Maureen Kenny about the company's plans at Aortech's headquarters in a business park on the outskirts of Glasgow.